Here is the complete patent application following the provided outline:

# DESCRIPTION  

## FIELD OF INVENTION  

The present invention relates generally to medical devices and systems for monitoring surgical wounds. More specifically, the invention pertains to a multi-modal bio-signal acquisition system capable of continuously monitoring peri-wound tissue oxygen saturation (StO2), temperature, and bioimpedance (BioZ) to detect and predict surgical site infections (SSIs). The system incorporates clinical-grade sensors and advanced machine learning algorithms to provide early warning of infection, enabling timely intervention. The invention is particularly suited for post-discharge monitoring of patients who have undergone surgical procedures.  

## BACKGROUND  

Surgical site infections remain one of the most prevalent complications following surgical procedures, occurring in approximately 2-5% of patients undergoing inpatient surgery. These infections impose significant burdens on both patients and healthcare systems, leading to extended hospital stays, increased mortality rates, and substantial additional costs. Current methods for detecting SSIs rely primarily on clinical observation of symptoms such as redness, swelling, and purulent discharge. However, these signs often manifest only after the infection has become established, delaying treatment and worsening outcomes.  

Post-discharge surveillance of surgical wounds presents particular challenges, as approximately 69% of SSIs are detected after patients leave the hospital. Existing monitoring methods, including telephone interviews and outpatient clinic visits, lack sensitivity and often fail to identify infections in their early stages. There exists a critical need for objective, continuous monitoring systems that can detect physiological changes associated with developing infections before clinical symptoms appear.  

Previous attempts to develop wound monitoring technologies have focused on single parameters such as temperature or pH. While these systems demonstrate some predictive capability, their accuracy and reliability remain limited. Near-infrared spectroscopy has shown promise in measuring tissue oxygenation, but existing implementations lack the multi-modal approach needed for comprehensive wound assessment. Current systems also fail to integrate advanced machine learning techniques that could improve early detection of infection.  

The present invention addresses these limitations through a novel combination of multi-parameter sensing and predictive analytics. By continuously monitoring multiple physiological biomarkers and analyzing their patterns through sophisticated algorithms, the system provides clinicians with actionable insights into wound healing status. This approach enables earlier intervention, potentially reducing complications, healthcare costs, and mortality associated with surgical site infections.  

## SUMMARY  

The invention provides a comprehensive system for early detection and prediction of surgical site infections through continuous multi-parameter monitoring and advanced data analysis. The system comprises a sensor apparatus incorporating near-infrared spectroscopy for tissue oxygen saturation measurement, a digital temperature sensor, and a bioimpedance measurement subsystem. These components are integrated into a wearable device that attaches to the peri-wound area, enabling continuous data collection without restricting patient mobility.  

The sensor apparatus interfaces with a bio-signal acquisition system that processes and stores the collected data. The system employs sophisticated signal processing techniques to filter motion artifacts and extract meaningful features from the raw sensor data. A machine learning model analyzes these features to detect patterns indicative of infection, providing predictions with lead times of up to 48 hours before clinical symptoms appear.  

Key innovations of the system include:  
1. A multi-modal sensing approach combining tissue oxygenation, temperature, and bioimpedance measurements for comprehensive wound assessment  
2. Advanced signal processing algorithms that compensate for motion artifacts and environmental noise  
3. A machine learning framework utilizing ensemble methods to improve prediction accuracy  
4. Wireless connectivity enabling remote monitoring and real-time alerts  
5. A wearable form factor designed for patient comfort and long-term use  

The system has demonstrated particular efficacy in detecting superficial incisional infections caused by Methicillin-Susceptible Staphylococcus Aureus (MSSA). Experimental results show the system can identify developing infections up to 24 hours before clinical diagnosis, with an area under the ROC curve (AUC) of 0.80. This early warning capability enables timely administration of antibiotics and other interventions, potentially reducing complications and improving patient outcomes.  

## DETAILED DESCRIPTION OF THE DISCLOSURE  

The multi-modal bio-signal acquisition system comprises several key components that work in concert to monitor wound healing and detect early signs of infection. The system architecture includes sensor modules, a data acquisition unit, signal processing algorithms, and predictive analytics modules.  

**Sensor Apparatus:**  
The core sensing unit incorporates three distinct measurement modalities:  
1. A near-infrared spectroscopy (NIRS) subsystem for tissue oxygen saturation (StO2) measurement, featuring dual-wavelength LEDs (730 nm and 850 nm) and a large-area silicon photodiode detector  
2. A high-precision digital temperature sensor with ±0.1°C accuracy  
3. A bioimpedance measurement system capable of generating signals up to 200 kHz  

These sensors are integrated into a compact, wearable module measuring approximately 10 cm × 6 cm × 3 cm. The module features medical-grade silicone encapsulation for patient comfort and durability. An innovative optical design ensures consistent sensor-skin contact while minimizing motion artifacts. The source-detector separation distance of 50 mm optimizes the depth of tissue oxygenation measurement while maintaining signal integrity.  

**Data Acquisition System:**  
The sensor module interfaces with a portable data acquisition unit that manages power, data storage, and wireless communication. The unit incorporates:  
1. A high-performance microcontroller with ample processing power for onboard signal conditioning  
2. Secure data storage capable of retaining several weeks of continuous monitoring data  
3. Bluetooth Low Energy (BLE) connectivity for wireless data transmission  
4. A rechargeable lithium polymer battery providing extended operation between charges  

The system employs a burst-mode sampling strategy, collecting data in one-minute intervals every ten minutes to balance power consumption with data resolution. This approach enables continuous monitoring for up to seven days on a single charge.  

**Signal Processing:**  
Raw sensor data undergoes sophisticated preprocessing to extract meaningful physiological signals. The processing pipeline includes:  
1. Motion artifact detection and removal using data from an integrated inertial measurement unit  
2. Digital filtering to eliminate environmental noise and baseline drift  
3. Feature extraction using moving window analysis to identify temporal patterns in the data  

The system extracts approximately 90 distinct features from the processed signals, including statistical measures (mean, variance, percentiles), temporal characteristics (slopes, derivatives), and frequency-domain features. These features serve as inputs to the machine learning model.  

**Machine Learning Framework:**  
The predictive analytics module employs an ensemble machine learning approach combining multiple algorithms to improve detection accuracy. Key components include:  
1. A bagging (bootstrap aggregating) technique to reduce variance and improve generalization  
2. Stacked generalization to combine predictions from multiple base models  
3. Class balancing methods to address the inherent imbalance between infected and non-infected cases  

The model outputs include:  
1. Real-time assessment of current wound status (infected/non-infected)  
2. Predictive alerts for developing infections (24-hour and 48-hour forecasts)  
3. Confidence intervals quantifying prediction reliability  

**Clinical Implementation:**  
The system is designed for seamless integration into clinical workflows. Key implementation features include:  
1. A disposable adhesive interface for secure sensor attachment to the peri-wound area  
2. Wireless synchronization with hospital electronic health record systems  
3. Customizable alert thresholds based on patient risk factors  
4. Mobile and web-based interfaces for clinician access  

**Experimental Validation:**  
The system has been rigorously tested in porcine models, demonstrating strong correlation between sensor-derived biomarkers and clinical infection indicators. Key findings include:  
1. Tissue oxygen saturation shows statistically significant differences between infected and non-infected wounds within 12-50 hours post-inoculation  
2. Wound temperature differences become significant between 24-72 hours post-inoculation  
3. Bioimpedance changes show significant divergence between 72-120 hours post-inoculation  

The machine learning model achieved an area under the ROC curve (AUC) of 0.77 for current infection detection, 0.80 for 24-hour prediction, and 0.74 for 48-hour prediction. These results demonstrate the system's ability to provide clinically actionable predictions well before visible symptoms appear.  

**Alternative Embodiments:**  
The system can be adapted for various clinical scenarios through modifications including:  
1. Integration of additional sensors (pH, perfusion, pulse rate)  
2. Customized machine learning models for specific surgical specialties  
3. Miniaturized form factors for discreet wear  
4. Extended battery life configurations for long-term monitoring  

The invention represents a significant advance in postoperative care, providing clinicians with an objective, continuous monitoring solution that can detect surgical site infections at their earliest stages. By enabling timely intervention, the system has potential to reduce complications, lower healthcare costs, and improve patient outcomes across a wide range of surgical procedures.